Sun Bioscience Overview

  • Founded
  • 2015

Founded
  • Status
  • Private

  • Employees
  • 15

Employees
  • Latest Deal Type
  • Debt

  • Latest Deal Amount
  • $547K

  • Investors
  • 9

Sun Bioscience General Information

Description

Developer of a drug culture platform intended to deliver personalized medicine through patient-specific organoids. The company's platform uses three-dimensional (3D) miniaturized tissues to mimic organ functions that are derived from stem cells, enabling professionals to accelerate the translation of stem cell research to clinics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • EPFL Innovation Park
  • Building D
  • 1015 Lausanne
  • Switzerland
+41 078 000 00 00

Sun Bioscience Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sun Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Debt - General 11-May-2021 $547K 00000 Completed Generating Revenue
5. Seed Round 19-Jan-2021 00000 00000 00000 Completed Generating Revenue
4. Grant 01-Dec-2020 00000 00000 Completed Startup
3. Accelerator/Incubator 05-Feb-2019 00000 Completed Startup
2. Grant 15-Dec-2017 $59.1K $100K Completed Startup
1. Accelerator/Incubator 04-Jun-2015 $100K $100K Completed Startup
To view Sun Bioscience’s complete valuation and funding history, request access »

Sun Bioscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Sun Bioscience’s complete cap table history, request access »

Sun Bioscience Patents

Sun Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3102043-A1 Well for cultivating biological material Pending 30-May-2018 000000000
EP-3802776-A1 Well for cultivating biological material Pending 30-May-2018 000000000
JP-2021525096-A Wells for culturing biomaterials Pending 30-May-2018 000000000 00
US-20210301237-A1 Well for cultivating biological material Pending 30-May-2018 C12M23/12

Sun Bioscience Executive Team (3)

Name Title Board Seat Contact Info
Nathalie Brandenberg Ph.D Co-Founder, Co-Chief Executive Officer, Chief Operating Officer & Board Member
Sylke Hoehnel Ph.D Co-Founder, Co-Chief Executive Officer & Chairman
Jeroen Van Den Oever Chief Financial Officer & Board Member
To view Sun Bioscience’s complete executive team members history, request access »

Sun Bioscience Board Members (4)

Name Representing Role Since
Jeroen Van Den Oever Sun Bioscience Chief Financial Officer & Board Member 000 0000
Johan Hyllner Self Board Member 000 0000
Martin Lukas Self Board Member 000 0000
Sylke Hoehnel Ph.D Sun Bioscience Co-Founder, Co-Chief Executive Officer & Chairman 000 0000
To view Sun Bioscience’s complete board members history, request access »

Sun Bioscience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sun Bioscience Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Acequia Capital Angel Group Minority 000 0000 000000 0
Possible Ventures Venture Capital Minority 000 0000 000000 0
MassChallenge Accelerator/Incubator Minority 000 0000 000000 0
Startlab Biopole Accelerator/Incubator 000 0000 000000 0
VentureLab Accelerator/Incubator 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »